Clinical Trial Update: Ticagrelor in Comparison to Prasugrel for Early Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI) [Phase 4]

View source ↗

Summary

Phase 4 study comparing ticagrelor to prasugrel for early inhibition of platelet reactivity in STEMI patients undergoing primary PCI. The trial status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• PRASUGREL (prasugrel)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: University of Patras | Conditions: Platelet Reactivity | Phase 4 | Status: COMPLETED